Skip to main content

Table 1 Patient Characteristics and Statin Treatment

From: Carotid plaque regression following 6-month statin therapy assessed by 3T cardiovascular magnetic resonance: comparison with ultrasound intima media thickness

Treatment Groups Age (year)/Gender Baseline Treatment (mg) Treatment During Study (mg)
A. Statin Increase: Initiation    
1 79/F none atorvastatin 80
2 72/M none simvastatin 20
3 68/F none atorvastatin 40
4 56/F none pravastatin 40
5 86/M none atorvastatin 20
6 46/M none rosuvastatin 40
Statin Increase    
7 58/M atorvastatin 10 atorvastatin 80
8 72/F simvastatin 10 atorvastatin 80
9 87/M lovastatin 40 atorvastatin 80
10 61/M simvastatin 40 simvastatin 80
11 73/M pravastatin 80 atorvastatin 80
12 65/M atorvastatin 10 atorvastatin 40
13 66/M simvastatin 20 simvastatin 40
B. Statin Maintain    
14 62/M atorvastatin 40 simvastatin 20
15 61/M atorvastatin 10 simvastatin 20
16 71/M lovastatin 40 lovastatin 40
17 64/M simvastatin 80 simvastatin 80
18 57/M simvastatin 40 (noncompliant with prescribed treatment) simvastatin 40 (noncompliant with prescribed treatment)
19 71/M simvastatin 5 simvastatin 5
20 63/M Ezetimibe 10/simvastatin 20 Ezetimibe 10/simvastatin 20
21 56/F simvastatin 10 simvastatin10
22 65/M atorvastatin 10 atorvastatin 10
23 82/M simvastatin 20 simvastatin 20
24 60/M simvastatin 20 simvastatin 20
25 81/F atorvastatin 10 atorvastatin 10
26 61/M pravastatin 40 pravastatin 40